Neuroblastoma (NB), the most prevalent extracranial solid tumor in children, poses a significant therapeutic challenge due to its metastasis and high heterogeneity. A recent study leveraging single-cell RNA sequencing (scRNA-seq) has uncovered vital molecular mechanisms underlying NB’s progression and metastasis, shedding light on potential therapeutic targets.
Ipsen joins the ADC club with deal worth up to $900m – Pharmaceutical Technology
Share this article Ipsen signed a deal with Sutro Biopharma for ADC development. Credit: HJBC via Shutterstock Ipsen has joined the slew of companies developing
April 2, 2024